UK markets open in 42 minutes
  • NIKKEI 225

    27,772.93
    +305.70 (+1.11%)
     
  • HANG SENG

    24,892.52
    +764.67 (+3.17%)
     
  • CRUDE OIL

    86.90
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    1,840.20
    -3.00 (-0.16%)
     
  • DOW

    35,028.65
    -339.82 (-0.96%)
     
  • BTC-GBP

    30,828.17
    +259.31 (+0.85%)
     
  • CMC Crypto 200

    998.49
    +3.74 (+0.38%)
     
  • ^IXIC

    14,340.25
    -166.64 (-1.15%)
     
  • ^FTAS

    4,273.79
    +10.75 (+0.25%)
     

$1.6 Billion Worldwide Pharmaceutical Drug Delivery Market Expected to Grow at a CAGR of 5.9% Between 2021 and 2026

·4-min read

Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes), Application (Cancer, Diabetes), Facility of Use (Hospitals), COVID-19 Impact - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical drug delivery market is projected to reach USD 2,206.5 billion by 2026 from USD 1,656.9 billion in 2021, at a CAGR of 5.9% during the forecast period.

Growth in the pharmaceutical drug delivery market can largely be attributed to factors such as the rising prevalence of chronic diseases, growing biologics market, increasing R&D investments, and technological advancements & new product launches.

On the other hand, the risk of needlestick injuries and the increased pricing pressure is expected to limit the market growth to some extent in the coming years.

The topical drug delivery segment is expected to grow at the highest CAGR during the forecast period

Based on route of administration, the pharmaceutical drug delivery market is segmented into oral, pulmonary, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.

The topical drug delivery segment accounted for the highest CAGR of the pharmaceutical drug delivery market. This can be attributed to convenience and the ease of use, the ease of dosage, painless and non-invasive administration, and enhanced patient compliance.

The infectious diseases segment is expected to account for the largest share of the pharmaceutical drug delivery market

Based on application, the pharmaceutical drug delivery market is segmented into cancer, infectious diseases, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. In 2020, the infectious diseases segment accounted for the largest share of the pharmaceutical drug delivery market.

The large share of this market segment can be attributed to the increasing prevalence of infectious diseases across the globe, increasing R&D expenditure for new drugs owing to the current COVID-19 pandemic scenario, and the rising number of FDA approvals for such drugs.

Asia Pacific is expected to account for the highest CAGR for players operating in the pharmaceutical drug delivery market

During the forecast period, the Asia Pacific is expected to be the fastest-growing regional market for pharmaceutical drug delivery.

The rapid rise in the geriatric population, increased prevalence of chronic diseases, increased healthcare expenditure, increased R&D activities conducted in this region, growth in technological collaborations for pharmaceutical drug delivery technologies, favourable reimbursement policies, and growth in disposable incomes in the emerging Asian economies, such as China and India, are factors that are expected to drive the growth of the APAC market during the forecast period.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global pharmaceutical drug delivery market. The report analyzes this market by route of administration, application, and facility of use

  • Solution Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global pharmaceutical drug delivery market

  • Market Development: Comprehensive information on the lucrative emerging markets by route of administration, applications, and facility of use

  • Market Diversification: Exhaustive information about new product enhancements, growing geographies, recent developments, and investments in the global pharmaceutical drug delivery market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global pharmaceutical drug delivery market.

Key Topics Covered:

Market Overview

  • Introduction

  • Market Dynamics

  • Market Drivers

  • Rising Prevalence of Chronic Diseases

  • Growth in the Biologics Market

  • Technological Advancements and New Product Launches

  • Increasing Investments in Pharmaceutical R&D

  • Market Restraints

  • Risk of Needlestick Injuries

  • Market Opportunities

  • Self-Administration and Home Care

  • Rising Demand for Biosimilars and Biologics

  • Market Challenges

  • Pricing Pressure

  • COVID-19 Impact on the Pharmaceutical Drug Delivery Market

  • Industry Trends

  • Increasing Adoption of Wearable Drug Delivery Technologies

  • Advancements in Technologies and Designs

  • Regulatory Analysis

  • Porter's Five Forces Analysis

  • Threat from New Entrants

  • Threat from Substitutes

  • Bargaining Power of Suppliers

  • Bargaining Power of Buyers

  • Intensity of Competitive Rivalry

  • Value Chain Analysis

  • Ecosystem Mapping

  • Trends/Disruptions Impacting Customers' Business

  • Patent Analysis

  • Patent Publication Trends for Pharmaceutical Drug Delivery Technologies

  • Insights: Jurisdiction and Top Applicant Analysis

Pharmaceutical Drug Delivery Market, by Route of Administration

Pharmaceutical Drug Delivery Market, by Application

Pharmaceutical Drug Delivery Market, by Facility of Use

Pharmaceutical Drug Delivery Market, by Region

Companies Mentioned

  • 3M

  • Abbvie Inc.

  • Amgen, Inc.

  • Antares Pharma, Inc.

  • Astrazeneca plc

  • Bayer Ag

  • Becton, Dickinson and Company

  • Boehringer Ingelheim

  • Boston Scientific Corporation

  • Bristol-Myers Squibb

  • Eli Lilly and Company

  • F. Hoffmann-La Roche Ag

  • Genmab A/S

  • Gerresheimer Ag

  • Gilead Sciences, Inc.

  • GlaxoSmithKline plc

  • Ideaya Biosciences, Inc.

  • Johnson & Johnson

  • Kite Pharma

  • Merck & Co., Inc.

  • Nimbus Therapeutics

  • Novartis International Ag

  • Pfizer Inc.

  • Sanofi

  • Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/xhl5qm

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting